Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Generic Manufacturer Recalls Several Drug Products
Actavis Totowa LLC, a generic drug manufacturer, has voluntarily recalled all drug products manufactured at its Little Falls, New Jersey facility. An FDA inspection at Little Falls revealed operations which did not meet the FDA's or Actavis' standards for good manufacturing practices. This recall includes all MULTIVITAMINS manufactured by Actavis Totowa, LLC, including Multi-ret Folic 500 mg tablets, Multi-vita-bets FL 0.25 mg, 0.5 mg, and 1 mg tablets, Multi-vita-bets FL & FE 0.5 mg and 1 mg tablets, Trivita FL 1 mg tablets, Vitacon Forte capsules, Vitaplex Plus tablets, and Vitaplex (FC) tablets. For more information, please visit: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2008/ucm112477.htm or http://www.actavis.us/RecallFAQ
Learn More

Generic Manufacturer Recalls Several Drug Products
Actavis Totowa LLC, a generic drug manufacturer, has voluntarily recalled all drug products manufactured at its Little Falls, New Jersey facility. An FDA inspection at Little Falls revealed operations which did not meet the FDA's or Actavis' standards for good manufacturing practices. This recall includes all Vitaplex and Vitaplex Plus tablets manufactured by Actavis Totowa, LLC. For more information, please visit: http://www.fda.gov/Safety/Recalls/ArchiveRecalls/2008/ucm112477.htm or http://www.actavis.us/RecallFAQ
Learn More

Date Published Title Drug Source
2008-08-05 Generic Manufacturer Recalls Several Drug Products Multivitamin Manufacturer
2008-08-05 Generic Manufacturer Recalls Several Drug Products Vitaplex Manufacturer
2008-08-05 Generic Manufacturer Recalls Several Drug Products Vitaplex Comp Manufacturer
2008-08-05 Generic Manufacturer Recalls Several Drug Products Vitamin K Manufacturer
2008-08-08 Combination use can lead to rare condition of muscle damage Simvastatin FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Amiodarone FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Lovastatin FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Atorvastatin FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Ezetimibe with Simvastatin FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Atorvastatin and Amlodipine FDA
2008-08-08 Combination use can lead to rare condition of muscle damage Lovastatin and Niacin FDA
2008-08-11 Recall - single lot of Watson brand 75 mcg/hr Fentanyl Transdermal System patches Fentanyl Manufacturer
2008-08-11 Potential increased risk of birth defects Topiramate MediGuard CRT
2008-08-12 Monitor for Injection Site Reactions Naltrexone FDA
2008-08-12 Angioedema and ACE inhibitors Captopril MediGuard CRT
2008-08-12 Angioedema and ACE inhibitors Enalapril MediGuard CRT
2008-08-12 Angioedema and ACE inhibitors Lisinopril MediGuard CRT
2008-08-12 Angioedema and ACE inhibitors Benazepril MediGuard CRT
2008-08-12 Angioedema and ACE inhibitors Ramipril MediGuard CRT
2008-08-12 Angioedema and ACE inhibitors Fosinopril MediGuard CRT